Bioengineered · 2019 · 67 citations · 24 references
Life SciencesOncologyPharmacologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionMalignant NeoplasmsOncogenic Signaling PathwaysThyroid CancerAnticancer ActivityCancer Signaling PathwaysEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersSignaling Pathways In EmtSmad Signaling PathwayTransforming Growth Factor-beta SignalingVimentin Expression
Transforming growth factor (TGF)-β1 plays a crucial role in the epithelial-to-mesenchymal transition (EMT) in many cancer types and in thyroid cancers. Epigallocatechin-3-gallate (EGCG), the most important ingredient in the green tea, has been reported to possess antioxidant and anticancer activities. However, the cellular and molecular mechanisms explaining its action have not been completely understood. In this study, we found that EGCG significantly suppresses EMT, invasion and migration in anaplastic thyroid carcinoma (ATC) 8505C cells in vitro by regulating the TGF-β/Smad signaling pathways. EGCG significantly inhibited TGF-β1-induced expression of EMT markers (E-cadherin reduction and vimentin induction) in 8505C cells in vitro. Treatment with EGCG completely blocked the phosphorylation of Smad2/3, translocation of Smad4. Taken together, these results suggest that EGCG suppresses EMT and invasion and migration by blocking TGFβ/Smad signaling pathways.
24
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A. Mani, Wenjun Guo, Mai-Jing Liao et al. · Cell · 2008 · 8.7K citations · Full text
Vasily Vasko, Allan V. Espinosa, William T. Scouten et al. · Proceedings of the National Academy of Sciences · 2007 · 312 citations · Full text
Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
Mark J. Anderton, Howard R. Mellor, Alex Bell et al. · Toxicologic Pathology · 2011 · 286 citations